Biogen (BIIB), Elan (ELN) Get FDA Approval for TYSABRI Label Change; Will Epand MS Market

Go back to Biogen (BIIB), Elan (ELN) Get FDA Approval for TYSABRI Label Change; Will Epand MS Market
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 216.78 +2.43 (1.13%)
Previous Close $214.35    52 Week High $333.65 
Open $217.76    52 Week Low $223.02 
Day High $219.12    P/E 27.76 
Day Low $215.00    EPS $7.81 
Volume 722,348       

Quest Diagnostics (NYSE: DGX) Delayed: 244.39 +3.09 (1.28%)
Previous Close $241.30    52 Week High $86.85 
Open $240.33    52 Week Low $59.66 
Day High $244.70    P/E 46.02 
Day Low $239.43    EPS $5.31 
Volume 1,263,230       

Elan Corp. PLC ADS (NYSE: ELN) Delayed: 18.12 --0 (-0%)
Previous Close $18.12    52 Week High $18.21 
Open $18.12    52 Week Low $9.37 
Day High $18.12    P/E N/A 
Day Low $18.12    EPS $0.00 
Volume 100